| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 3217 |
| 1 | LENALIDOMIDE | 3166 |
| 2 | CYCLOPHOSPHAMIDE | 3113 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 3113 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 3113 |
| 5 | CARBOPLATIN | 2841 |
| 6 | DEXAMETHASONE | 2780 |
| 7 | DEXAMETHASONE 1.5 MG | 2779 |
| 8 | PALBOCICLIB | 2299 |
| 9 | PACLITAXEL | 2045 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM | 856 | 0.0715 |
| 1 | BENDAMUSTINE HYDROCHLORIDE | 424 | 0.0498 |
| 2 | APREPITANT | 352 | 0.0468 |
| 3 | ERIBULIN MESYLATE | 171 | 0.0457 |
| 4 | PALONOSETRON HYDROCHLORIDE | 244 | 0.0454 |
| 5 | DEXAMETHASONE SODIUM PHOSPHATE | 458 | 0.0441 |
| 6 | EPIRUBICIN HYDROCHLORIDE | 272 | 0.0419 |
| 7 | POLATUZUMAB VEDOTIN | 421 | 0.0413 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 327 | 0.0391 |
| 9 | ERGOCALCIFEROL | 967 | 0.0325 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 5316 |
| 1 | Corticosteroid [EPC] | 5254 |
| 2 | Thalidomide Analog [EPC] | 4264 |
| 3 | Kinase Inhibitor [EPC] | 4137 |
| 4 | Atypical Antipsychotic [EPC] | 3993 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 3921 |
| 6 | Alkylating Drug [EPC] | 3790 |
| 7 | Microtubule Inhibitor [EPC] | 3018 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2937 |
| 9 | Osmotic Laxative [EPC] | 2491 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 655 | 0.1119 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 360 | 0.0413 |
| 2 | Provitamin D2 Compound [EPC] | 967 | 0.0325 |
| 3 | CD33-directed Immunoconjugate [EPC] | 109 | 0.0297 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 179 | 0.0283 |
| 5 | Dopamine-2 Receptor Antagonist [EPC] | 175 | 0.0224 |
| 6 | Estrogen Receptor Antagonist [EPC] | 851 | 0.0210 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 441 | 0.0204 |
| 8 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1975 | 0.0200 |
| 9 | Platinum-based Drug [EPC] | 5316 | 0.0194 |